The lack of statistically significant effect on this outcome, which was repeatedly demonstrated to improve in the CVOTs with GLP-1 RAs [12], can be explained by the irregularity of UACR sampling in real-world setting compared with CVOTs
Beyond their effects on insulin and glucagon, GLP-1 medications slow gastric emptying, which moderates the rate at which nutrients enter the bloodstream after meals
Studies have shown that many people regain a lot of the lost weight within months of stopping, especially if they go back to old eating patterns
The time of day for your tirzepatide shot also matters for managing side effects
Thats because we did not have any pharmaceutical treatments (until ezdiffra (resmetirom) from Madrigal in 2024), and until late stage fibrosis & cirrhosis develops, most liver disease is fully reversible
Both sides contain verifiable facts